tTregs, pTregs, and iTregs: Similarities and differences

Immunological Reviews

Volumn 259, Issue 1, 2014, Pages 88-102

  Shevach, Ethan M ^a   Thornton, Angela M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Helios; IL 10; Infectious tolerance; Organ specific autoimmunity; Stability; Treg cells

Indexed keywords

CD83 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; POLYCLONAL ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HELIOS; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL SURFACE; COMPLEMENT SYSTEM; DENDRITIC CELL; EFFECTOR CELL; HUMAN; ITREG; LYMPHOCYTE MIGRATION; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PTREG; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TTREG;

HELIOS; IL-10; INFECTIOUS TOLERANCE; ORGAN-SPECIFIC AUTOIMMUNITY; STABILITY; TREG CELLS;

ANIMALS; AUTOIMMUNE DISEASES; CELL MOVEMENT; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; PHENOTYPE; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84897941063     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12160     Document Type: Article

References (67)

1. Abbas AK, et al. Regulatory T cells: recommendations to simplify nomenclature. Nat Immunol 2013;14:307-308.
2. Floess S, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
3. Polansky JK, et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008;38:165-1663.
4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
6. + regulatory T cells. Nat Immunol 2003;4:330-336.
7. + T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J Immunol 2005;175:7135-7142.
8. Suri-Payer E, Kehn PI, Cheever AW, Shevach EM. Pathogenesis of post-thymectomy autoimmune gastritis: identification of anti-H/K adenosine triphosphate-reactive T cells. J Immunol 1996;157:1799-1805.
9. McHugh RS, Shevach EM, Margulies DH, Natarajan K. A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur J Immunol 2001;31:2094-2103.
10. Candon S, McHugh RS, Fourcas G, Natarajan K, Shevach EM, Margulies DH. Spontaneous organ-specific TH2-mediated autoimmunity in TCR transgenic mice. J Immunol 2004;172:3157-3166.
11. Stummvoll GH, et al. Th1, Th2 and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and susceptibility to suppression by regulatory T cells. J Immunol 2008;181:1908-1916.
12. + regulatory T cells in regional lymph node. J Exp Med 2005;202:771-781.
13. high regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002;169:4712-4716.
14. Davidson TS, Shevach EM. Polyclonal Treg cells modulate T effector cell trafficking. Eur J Immunol 2011;41:2862-2870.
15. Thangada S, et al. Cell surface residence of sphingosine 1-phosphae receptor 1 on lymphocytes determines lymphocyte egress kinetics. J Exp Med 2010;207:1475-1483.
16. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 2002;99:8213-8218.
17. Tang Q, et al. In vitro expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2002;199:1455-1465.
18. Chen W, et al. Conversion of peripheral CD4+CD25+ naïve T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
19. + T regulatory cells. J Immunol 2007;178:4022-4026.
20. + regulatory T cell development. J Immunol 2008;181:3285-3290.
21. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of IL-2. Nat Immunol 2005;6:152-162.
22. + regulatory lymphocytes through the induction of anergy and infectious tolerance. J Immunol 2008;180:6329-6337.
23. Huter EN, Punkosdy GA, Glass DD, Cheng LI, Ward JM, Shevach EM. TGF-β-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol 2008;38:1814-1821.
24. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 2007;179:4685-4693.
25. Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM. Cutting edge: antigen-specific TGFβ-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol 2008;181:8209-8213.
26. Korn T, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007;13:423-431.
27. Shevach EM. Biological functions of regulatory T cells. Adv Immunol 2011;112:137-176.
28. Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM. IL-2 controls the stability of Foxp3 expression in TGF-β-induced Foxp3+ T cells in vivo. J Immunol 2011;186:6329-6337.
29. Cederbom L, Hall H, Ivars F. CD4+ CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-1543.
30. + T cells. Immunity 2003;19:877-889.
31. Wing K, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322:271-275.
32. Qureshi OS, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011;332:600-603.
33. Chattopadhay G, Shevach EM. Antigen-specific iTreg impair DC function via an IL-10/MARCH1-dependent mechanism. J Immunol 2013;191:5875-5884.
34. Shin JS, Ebersold M, Pypaert M, Delmarre L, Hartley A, Mellman I. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 2006;444:115-118.
35. De Gassart A, et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH 1 down-regulation. Proc Natl Acad Sci USA 2008;105:3491-3496.
36. Tze LE, et al. CD83 increases MHC class II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med 2011;208:149-165.
37. Rubtsov YP, et al. Regulatory T cell-derived IL-10 limits inflammation at environmental interfaces. Immunity 2008;28:546-558.
38. Zhang X, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004;16:249-256.
39. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ immunoregulatory T lymphocytes control Leishmania major persistence and the development of concomitant immunity. Nature 2002;420:502-507.
40. Weber SE, et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate disappearance of pathogenic Th1 cells in vivo. J Immunol 2006;176:4730-4739.
41. Webster KE, et al. In vivo expansion of T reg cells with IL-2 mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009;206:751-760.
42. Strainic MG, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naïve CD4+ T cells. Immunity 2008;28:425-435.
43. + regulatory T cells. Nat Immunol 2013;14:162-171.
44. + regulatory T cells confer infectious tolerance in a TGF-β-dependent manner. J Exp Med 2008;205:1975-1981.
45. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 2008;3:e2705.
46. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009;39:3315-3322.
47. + regulatory T cells. Proc Natl Acad Sci USA 2009;106:13445-13450.
48. Wang R, Zhu J, Dong Z, Shi M, Lu C, Springer TA. GARP regulates the bioavailability and activation of TGFβ. Mol Biol Cell 2012;23:1129-1139.
49. Edwards JO, Fujii H, Zhou AX, Creemers J, Unutmaz D, Shevach EM. Regulation of the expression of GARP/Latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation. J Immunol 2013;190:5506-5515.
50. Li M, Wan YY, Flavell RA. T cell-produced transforming factor beta 1 controls T cell tolerance and regulated Th1- and Th17-cell differentiation. Immunity 2007;26:579-591.
51. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25+Foxp3+ T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol 2007;178:6725-6729.
52. Tran DQ, Ramsey H, Shevach EM. Induction of Foxp3 expression in naïve human CD4+Foxp3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007;110:2983-2990.
53. + regulatory T cells generated with IL-2, TGF-β, and retinoic acid. PLoS ONE 2010;5:e15150.
54. Hippen KL, et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant 2011;11:1148-1157.
55. + T regulatory cells. J Immunol 2010;181:3433-3441.
56. John LB, Ward AC. The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 2011;48:1272-1278.
57. Kelley CM, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 1998;8:508-515.
58. Cai Q, Dierich A, Oulad-Abselghani M, Chan S, Kastner P. Helios deficiency has minimal impact on T cell development and function. J Immunol 2009;183:2303-2311.
59. + T regulatory cells". J Immunol 2010;185:7129.
60. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 2011;6:e24226.
61. + T reg cells. J Exp Med 2012;209:1723-1742.
62. Yadav M, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 2012;209:1713-1722.
63. Kim YC, et al. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion. Blood 2012;119:2810-2818.
64. Trzonkowski P, et al. First in man clinical results of the treatment of patients with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol 2009;133:22-26.
65. Brunstein CG, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011;20:1061-1070.
66. Di Ianni M, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011;117:3921-3928.
67. - regulatory T cells preserves β-cell function in type 1 diabetes in children. Diabetes Care 2012;35:1817-1820.